...
首页> 外文期刊>European journal of cardio-thoracic surgery: Official journal of the European Association for Cardio-thoracic Surgery >Outcomes and reoperations after total correction of complete atrio-ventricular septal defect.
【24h】

Outcomes and reoperations after total correction of complete atrio-ventricular septal defect.

机译:完全矫正房室间隔缺损后的结果和再次手术。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Surgical correction of complete atrio-ventricular septal defect (AVSD) achieves satisfactory results with low morbidity and mortality, but may require reoperation. Our recent operative results at mid-term were followed-up. METHODS: From June 2000 to December 2007, 81 patients (Down syndrome; n=60), median age 4.0 months (range 0.7-118.6) and weight 4.7kg (range 2.2-33), underwent complete AVSD correction. Patch closure for the ventricular septal defect (VSD; n=69) and atrial septal defect (ASD; n=42) was performed with left atrio-ventricular valve (LAVV) cleft closure (n=76) and right atrio-ventricular valve (RAVV) repair (n=57). Mortality, morbidity, and indications for reoperation were retrospectively studied; the end point 'time to reoperation' was analyzed using Kaplan-Meier curves. Follow-up was complete except in two patients and spanned a median of 28 months (range 0.4-6.1 years). RESULTS: In-hospital mortality was 3.7% (n=3) and one late death occurred. Reoperation was required in 7/79 patients (8.9%) for LAVV insufficiency (n=4), for a residual ASD (n=1), for right atrio-ventricular valve insufficiency (n=1), and for subaortic stenosis (n=1). At last follow-up, no or only mild LAVV and RAVV insufficiency was present in 81.3% and 92.1% of patients, respectively, and 2/3 of patients were medication-free. Risk factors for reoperation were younger age (<3 months; p=0.001) and lower weight (<4kg; p=0.003), and a trend towards less and later reoperations in Down syndrome (p<0.2). CONCLUSIONS: Surgical correction of AVSD can be achieved with low mortality and need for reoperation, regardless of Down syndrome or not. Immediate postoperative moderate or more residual atrio-ventricular valve insufficiency will eventually require a reoperation, and could be anticipated in patients younger than 3 months and weighing <4kg.
机译:背景:完全房室间隔缺损(AVSD)的手术矫正取得了令人满意的结果,发病率和死亡率均较低,但可能需要再次手术。我们对中期近期的手术结果进行了随访。方法:从2000年6月至2007年12月,对81例患者(唐氏综合症; n = 60),中位年龄4.0个月(范围0.7-118.6)和体重4.7kg(范围2.2-33)进行了全面的AVSD矫正。左房室瓣(LAVV)左房室闭合(n = 76)和右房室瓣(NSD)进行房间隔缺损(VSD; n = 69)和房间隔缺损(ASD; n = 42)的修补术RAVV)修复(n = 57)。回顾性研究死亡率,发病率和再次手术适应症。使用Kaplan-Meier曲线分析了终点“再手术时间”。除两名患者外,随访已完成,中位时间为28个月(范围0.4-6.1年)。结果:院内死亡率为3.7%(n = 3),发生了1例晚期死亡。 LAVV功能不全(n = 4),残余ASD(n = 1),右房室瓣膜功能不全(n = 1)和主动脉瓣狭窄(n = 7)的7/79患者(8.9%)需要再次手术= 1)。在最后一次随访中,分别有81.3%和92.1%的患者没有或仅有轻度的LAVV和RAVV功能不全,并且有2/3的患者没有药物治疗。再次手术的危险因素是年龄较小(<3个月; p = 0.001)和体重较轻(<4kg; p = 0.003),唐氏综合症的再次手术趋势也越来越少(p <0.2)。结论:无论是否患有唐氏综合症,均可通过AVSD手术矫正,死亡率低且需要再次手术。术后立即中度或更多残留的房室瓣膜功能不全最终将需要再次手术,并且可以预料不到3个月且体重<4kg的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号